Asia-Pacific Digital Pathology Market Size Expected to reach $0.39 billion by 2031 | CAGR of 10.6%

Asia-Pacific digital pathology market size was valued at $143.32 Million in 2021, and is projected to reach $393.33 Million by 2031, registering a CAGR of 10.6%. Digital pathology is a diagnosis technique carried out by the use of various computer technologies. Digitized specimen slide generates information that is managed by advanced computation and through virtual microscopy. Advances in medical science and computer technology have all contributed to the development of digital pathology.. It offers a high-resolution sample scanning, analysis of computer images, and online storage of digital slides which enables pathologists to examine slides without forensic evidence.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

Akoya Biosciences, Roche, Hamamatsu Photonics, Nikon Corporation, Qritive, Visiopharm A/S, Danaher Corporation, Koninklijke Philips, Indica Labs Inc., Aether AI

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/30630

On the basis of type, the Asia-Pacific digital pathology market is segmented into scanners, software and storage & communication system. In 2021, the scanners segment accounted for the largest share of the market. The dominance of this segment can be attributed to the advanced features provided by digital pathology scanners, such as whole slide imaging systems that conduct automated assays as well as repeated data analysis across experiments and produce high images, are the key drivers for the growth of the market. The software segment is anticipated to grow at a significant rate during the forecast period. Owing to the fact that digital pathology software provides a universal platform for pathology workflow to histo-technicians, pathologists, and administrators through diagnosis.

On the basis of application, the market is classified into teleconsultation, disease diagnosis, drug discovery and training & education. In 2021, the disease diagnosis segment exhibited the highest growth, and is anticipated to lead during the forecast period, owing to increase in use of digital pathology to diagnose various types of cancers and chronic diseases such as lung cancer, colorectal cancer, and breast cancer which is projected to boost the growth of the market.

The drug discovery segment is expected to grow at a considerable growth rate during the Asia-Pacific digital pathology market forecast period. Owing to increase in the productivity for drug development by reducing the volume of slides that need to be analyzed and provides increasingly accurate predictions of the images.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/30630

The clinical segment is anticipated to be the fastest growing segment during the forecast period. Owing to increase in demand of clinical trial training applications which can be reformatted to drive quality improvement in routine practice, hence, contributing in the growth of Asia-Pacific digital pathology market

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.co